AB Science & Daiichi Try Their Luck Again With EU Filings

 
• By Neena Brizmohun

The sponsors of Alsitek and quizartinib are hoping that new data generated for the drugs will resolve the concerns raised by the European Medicines Agency when it previously rejected the products for marketing in the EU.

Astrocyte and blood vessel
Alsitek is an investigative treatment for the fatal motor neuron disorder, ALS • Source: Shutterstock

More from Product Reviews

More from Pink Sheet